2007
DOI: 10.1016/j.mod.2007.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Cloning and characterization of a novel MyoD enhancer-binding factor

Abstract: Glucocorticoid-induced gene-1 (Gig1) was identified in a yeast one-hybrid screen for factors that interact with the MyoD core enhancer. The Gig1 gene encodes a novel C2H2 zinc finger protein that shares a high degree of sequence similarity with two known DNA binding proteins in humans, Glut4 enhancer factor and papillomavirus binding factor (PBF). The mouse ortholog of PBF was also isolated in the screen. The DNA binding domain of Gig1, which contains TCF-E-tail CR1 and CR2 motifs shown to mediate promoter spe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 34 publications
0
14
0
Order By: Relevance
“…While OTX2 displayed no intrinsic trans-activity when fused with Gal4-binding domain (Gal4-BD) in D425 cells (Figure 1H), we fused OTX2 with the VP16 trans-activation domain to test its trans-activation ability with the pMyoD-CER construct, since this can serve as an indirect readout of the association of OTX2 with the MyoD CER (38). VP16-OTX2 was capable of activating pMyoD-CER significantly above VP16 vector alone, while the VP16-OTX2-3M construct containing triple DNA-binding mutations in the homeobox domain (HD) lost this trans-activity (Figure 1H).…”
Section: Resultsmentioning
confidence: 99%
“…While OTX2 displayed no intrinsic trans-activity when fused with Gal4-binding domain (Gal4-BD) in D425 cells (Figure 1H), we fused OTX2 with the VP16 trans-activation domain to test its trans-activation ability with the pMyoD-CER construct, since this can serve as an indirect readout of the association of OTX2 with the MyoD CER (38). VP16-OTX2 was capable of activating pMyoD-CER significantly above VP16 vector alone, while the VP16-OTX2-3M construct containing triple DNA-binding mutations in the homeobox domain (HD) lost this trans-activity (Figure 1H).…”
Section: Resultsmentioning
confidence: 99%
“…Whole mount in situ hybridization with digoxigenin-labeled probes was performed as previously described (Henrique et al, 1995; Yamamoto et al, 2007), with minor modifications related to color development and storage. Briefly, for color development, embryos were incubated in BM Purple (Roche Applied Science) overnight at room temperature.…”
Section: Methodsmentioning
confidence: 99%
“…Embryos were subsequently transferred to 70% ethanol for 30 min at room temperature, rinsed in MABT and stored at 4°C in MABT. The MyoD probe has been previously described (Yamamoto et al, 2007). The Myf-5 probe represents a 613 nucleotide fragment of the Myf-5 cDNA that was amplified by PCR using the following primers: Forward: 5′-CATATGGACATGACGGACGGC -3′, Reverse: 5′-AGCTGGACACGGAGCTTTTA -3′.…”
Section: Methodsmentioning
confidence: 99%
“…X-gal Staining X-gal staining was performed as previously described 22 , with minor modifications. Mounted tissue sections were fixed in 0.2% glutaraldehyde for ten minutes on ice, rinsed briefly in phosphate-buffered saline solution, and rinsed in detergent solution (0.05% NP-40 and 0.01% sodium deoxycholate in phosphate-buffered saline solution) for ten minutes at 4°C.…”
Section: Tissue Preparation and Histologymentioning
confidence: 99%